You are using an outdated browser. Please upgrade your browser to improve your experience.

methylcobalamin deficiency type cblG

Disease Summary
Associated Targets (1)
Tbio

1


GARD Rare
Mondo Description Methylcobalamin deficiency cbl G type is a rare condition that occurs when the body is unable to process certain amino acids (building blocks of protein) properly. In most cases, signs and symptoms develop during the first year of life; however, the age of onset can range from infancy to adulthood. Common features of the condition include feeding difficulties, lethargy, seizures, poor muscle tone (hypotonia), developmental delay, microcephaly (unusually small head size), and megaloblastic anemia. Methylcobalamin deficiency cbl G type is caused by changes (mutations) in the MTR gene and is inherited in an autosomal recessive manner. Treatment generally includes regular doses of hydroxycobalamin (vitamin B12). Some affected people may also require supplementation with folates and betaine.
Uniprot Description An autosomal recessive inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine. It causes delayed psychomotor development, megaloblastic anemia, homocystinuria, and hypomethioninemia.
Mondo Term and Equivalent IDs
MONDO:0009609:  methylcobalamin deficiency type cblG
EFO:0005597: 
GARD:0002733: 
GARD:0003577: 
Orphanet:2170: 
SCTID:721187005: